Cargando…

Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients

BACKGROUND: Pemphigus vulgaris (PV) is an immunoglobulin G-mediated autoimmune bullous skin disease. Nonorgan-specific antibodies were detected in Tunisian and Brazilian pemphigus patients with different prevalence. MATERIALS AND METHODS: Fifty PV patients and fifty controls were screened for antinu...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh, Marwah Adly, Salem, Hedayat, El Azizy, Hoda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286753/
https://www.ncbi.nlm.nih.gov/pubmed/28216725
http://dx.doi.org/10.4103/0019-5154.198032
_version_ 1782504056484265984
author Saleh, Marwah Adly
Salem, Hedayat
El Azizy, Hoda
author_facet Saleh, Marwah Adly
Salem, Hedayat
El Azizy, Hoda
author_sort Saleh, Marwah Adly
collection PubMed
description BACKGROUND: Pemphigus vulgaris (PV) is an immunoglobulin G-mediated autoimmune bullous skin disease. Nonorgan-specific antibodies were detected in Tunisian and Brazilian pemphigus patients with different prevalence. MATERIALS AND METHODS: Fifty PV patients and fifty controls were screened for antinuclear antibodies (ANAs), anti-smooth muscle antibodies (ASMAs), anti-parietal antibodies (APAs), anti-mitochondrial antibodies, and Anti-nuclear cytoplasmic antibodies (ANCA) by indirect immunofluorescence. RESULTS: Thirty-nine patients were female and 11 were male. Fifteen patients did not receive treatment before while 35 patients were on systemic steroid treatment ± azathioprine. Twenty (40%) of the PV patients and 1 (2%) control had positive ANA. ANA was significantly higher in PV patients than controls, P < 0.0001. ASMAs were detected in 20 (40%) PV patients and none of the controls. ASMA was significantly higher in PV patients than controls, P < 0.0001. No significant difference was detected between treated and untreated regarding ANA, P - 0.11. However, there was a significant difference between treated and untreated regarding ASMA, P - 0.03. Six patients (12%) and none of the controls had positive APA. There was a significant difference between the patients and the controls in APA. P - 0.027. CONCLUSION: Egyptian PV patients showed more prevalent ANA, ASMA, and APA than normal controls. Follow-up of those patients is essential to detect the early development of concomitant autoimmune disease. Environmental factors might account for the variability of the nonorgan-specific antibodies among different populations.
format Online
Article
Text
id pubmed-5286753
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-52867532017-02-17 Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients Saleh, Marwah Adly Salem, Hedayat El Azizy, Hoda Indian J Dermatol Original Article BACKGROUND: Pemphigus vulgaris (PV) is an immunoglobulin G-mediated autoimmune bullous skin disease. Nonorgan-specific antibodies were detected in Tunisian and Brazilian pemphigus patients with different prevalence. MATERIALS AND METHODS: Fifty PV patients and fifty controls were screened for antinuclear antibodies (ANAs), anti-smooth muscle antibodies (ASMAs), anti-parietal antibodies (APAs), anti-mitochondrial antibodies, and Anti-nuclear cytoplasmic antibodies (ANCA) by indirect immunofluorescence. RESULTS: Thirty-nine patients were female and 11 were male. Fifteen patients did not receive treatment before while 35 patients were on systemic steroid treatment ± azathioprine. Twenty (40%) of the PV patients and 1 (2%) control had positive ANA. ANA was significantly higher in PV patients than controls, P < 0.0001. ASMAs were detected in 20 (40%) PV patients and none of the controls. ASMA was significantly higher in PV patients than controls, P < 0.0001. No significant difference was detected between treated and untreated regarding ANA, P - 0.11. However, there was a significant difference between treated and untreated regarding ASMA, P - 0.03. Six patients (12%) and none of the controls had positive APA. There was a significant difference between the patients and the controls in APA. P - 0.027. CONCLUSION: Egyptian PV patients showed more prevalent ANA, ASMA, and APA than normal controls. Follow-up of those patients is essential to detect the early development of concomitant autoimmune disease. Environmental factors might account for the variability of the nonorgan-specific antibodies among different populations. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5286753/ /pubmed/28216725 http://dx.doi.org/10.4103/0019-5154.198032 Text en Copyright: © 2017 Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Saleh, Marwah Adly
Salem, Hedayat
El Azizy, Hoda
Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients
title Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients
title_full Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients
title_fullStr Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients
title_full_unstemmed Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients
title_short Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients
title_sort autoantibodies other than anti-desmogleins in pemphigus vulgaris patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286753/
https://www.ncbi.nlm.nih.gov/pubmed/28216725
http://dx.doi.org/10.4103/0019-5154.198032
work_keys_str_mv AT salehmarwahadly autoantibodiesotherthanantidesmogleinsinpemphigusvulgarispatients
AT salemhedayat autoantibodiesotherthanantidesmogleinsinpemphigusvulgarispatients
AT elazizyhoda autoantibodiesotherthanantidesmogleinsinpemphigusvulgarispatients